A California federal court recently held that all governance token holders were responsible for any losses suffered in a security incident. Specifically, the court, in denying a motion to dismiss, ruled in part in favor of a...more
4/11/2023
/ Asset Tokens ,
Corporate Counsel ,
Cybersecurity ,
Data Breach ,
Decentralized Autonomous Organization (DAO) ,
Digital Assets ,
Investors ,
Limited Liability Company (LLC) ,
Negligence ,
Personal Liability ,
Putative Class Actions ,
Securities Tokens
Northern District of Illinois Grants Motion for Partial Reconsideration of Summary Judgment Decision Regarding Whether Former Walgreens CFO’s Statements Were Actionable; Securities Fraud Claims Against Chicken Producer for...more
3/23/2022
/ Antitrust Violations ,
Bid Rigging ,
Bristol-Myers Squibb ,
CEOs ,
CFOs ,
Class Action ,
Clinical Trials ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Dismissal With Prejudice ,
Dismissals ,
False Statements ,
Guilty Pleas ,
Investors ,
Misleading Statements ,
Partial Summary Judgments ,
Pharmaceutical Industry ,
Price-Fixing ,
Private Securities Litigation Reform Act of 1995 ,
PSLRA ,
Public Statements ,
Safe Harbors ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Share Price ,
Stock Drop Litigation ,
Walgreens
Delaware Federal Court Dismisses Shareholder Derivative Suit Concerning Lack of Board Diversity; California Federal Court Dismisses Shareholder Class Action Against Sorrento Therapeutics Regarding COVID-19 Treatment; Delaware...more
12/23/2021
/ Board of Directors ,
Cannabis-Related Businesses (CRBs) ,
Class Action ,
Coronavirus/COVID-19 ,
Derivative Suit ,
Discovery ,
Discovery Violations ,
Dismissals ,
Diversity ,
False Statements ,
Investment Fraud ,
Investors ,
Misleading Statements ,
Misrepresentation ,
Pharmaceutical Industry ,
Popular ,
Putative Class Actions ,
Rule 10b-5 ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Violations ,
Shareholder Litigation ,
Shareholders